Abstract
Evidence has emerged that nitric oxide (NO) plays a role in the pathogenesis of myocardial failure. The effects of NO in heart failure, as in other clinical situations, may be either beneficial or deleterious. It has been hypothesized that NO at relatively low levels appears to modulate the response of the myocardium to potentially deleterious stimuli, and thus in some situations may offset the progression of myocardial failure. On the other hand, at higher levels NO has the ability to impair normal myocardial function and to exert direct toxic effects in the myocardium, as it can in other tissues. The effects of higher levels of NO may be relevant to a variety of situations in which myocardial NO is increased. These include conditions in which there is a clear inflammatory reaction such as sepsis, myocarditis, transplant rejection or acute infarction. There is also evidence that NO production is increased above physiologic levels in the myocardium of patients with chronic heart failure. These observations have led to the concern that with increasing levels, NO may contribute to the pathogenesis of myocardial failure, and thus change from a friend to a foe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nathan C (1995) Natural resistance and nitric oxide.Cell82 (6): 873–876
Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM (1998) Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: Activation by angiotensin II in hypertension.Circ Res83 (12): 1271–1278
Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum.Proc Natl Acad Sci USA96 (2): 657–662
Elfering SL, Sarkela TM, Giulivi C (2002) Biochemistry of mitochondrial nitric-oxide synthase.J Biol Chem277 (41): 38079–38086
Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O’Rourke B et al (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.Nature416 (6878): 337–339
Pinsky DJ, Patton S, Mesaros S, Brovkovych V, Kubaszewski E, Grunfeld S, Malinski T (1997) Mechanical transduction of nitric oxide synthesis in the beating heart.Circ Res81(3): 372–379
Marshall HE, Merchant K, Stamler JS (2000) Nitrosation and oxidation in the regula-tion of gene expression.FASEB J14 (13): 1889–1900
Kanai AJ, Mesaros S, Finkel MS, Oddis CV, Birder LA, Malinski T (1997) Beta-adren-ergic regulation of constitutive nitric oxide synthase in cardiac myocytes. AmJ Physiol273 (4 Pt 1): C1371–1377
Belhassen L, Kelly RA, Smith TW, Balligand JL (1996) Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcriptionin vitroandin vivoby cyclic adenosine monophosphate in rat cardiac myocytes.J Clin Invest97 (8): 1908–1915
Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA (1996) Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha.J Biol Chem271 (2): 1111–1117
Xuan YT, Tang XL, Banerjee S, Takano H, Li RC, Han H, Qiu Y, Li JJ, Bolli R (1999) Nuclear factor-kappa-B plays an essential role in the late phase of ischemic preconditioning in conscious rabbits.Circ Res84 (9): 1095–1109
Macmicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis.Proc Natl Acad Sci USA94 (10): 5243–5248
Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC (1997). Bacterial infection induces nitric oxide synthase in human neutrophile.J Clin Invest99 (1): 110–116
Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH et al (1996) Expression of inducible nitric oxide synthase in human heart failure.Circulation93 (6): 1087–1094
Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM (1996) Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.Lancet347 (9009): 1151–1155
Thoenes M, Forstermann U, Tracey WR, Bleese NM, Nussler AK, Scholz H, Stein B (1996) Expression of inducible nitric oxide synthase in failing and non-failing human heart.J Mol Cell Cardiol28 (1): 165–169
Wildhirt SM, Dudek RR, Suzuki H, Bing RJ (1995) Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction.Int J Cardiol50 (3): 253–261
Ishiyama S, Hiroe M, Nishikawa T, Abe S, Shimojo T, Ito H, Ozasa S, Yamakawa K, Matsuzaki M, Mohammed MU (1997) Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats.Circulation95 (2): 489–496
MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S (1997) Circulating interleukin-6 in severe heart failure. AmJ Cardiol79 (8): 1128–1131
Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD).JAmColl Cardiol27: 1201–1206
Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart.Circulation93: 704–711
Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.N Engl J Med311: 819–823
Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA (1994) Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytesin vitro. J Biol Chem269 (44): 27580–27588
Oddis CV, Simmons RL, Hattler BG, Finkel MS (1994) Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes.Biochem Biophys ResComm 205: 992–997
Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ (1999) Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.Circulation99 (23): 3009–3016
Gulick T, Pieper SJ, Murphy MA, Lange LG, Schreiner GF (1991) A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses.Circulation84 (1): 313–321
Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW (1993) Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.J Clin Invest91 (5): 2314–2319
Balligand JL, Ungureanu-Longrois D, Simmons WW, Kobzik L, Lowenstein CJ, Lamas S, Kelly RA, Smith TW, Michel T (1995) Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. AmJ Physiol268 (3 Pt 2): H1293–303
Keaney JF, Jr., Hare JM, Balligand JL, Loscalzo J, Smith TW, Colucci WS (1996) Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. AmJ Physiol271 (6 Pt 2): H2646–652
Hare JM, Loh E, Creager MA, Colucci WS (1995) Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.Circulation92 (8): 2198–2203
Hare JM, Givertz MM, Creager MA, Colucci WS (1998) Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of ß-adrenergic inotropic responsiveness.Circulation97: 161–166
Drexler H, Kastner S, Strobel A, Studer R, Brodde E, Hasenfuss G (1998) Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.JAmColl Cardiol32 (4): 955–963
Packer M, Colucci WS, Sackner-Bernstein JD, Liang C, Goldscher DA, Freeman I et al (1996) Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial. Prospective randomized evaluation of carvedilol on symptoms and exercise.Circulation94 (11): 2793–2799
Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA (1996) Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US carvedilol heart failure study group.Circulation94 (11): 2800–2806
Gealekman 0, Abassi Z, Rubinstein I, Winaver J, Binah O (2002) Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.Circulation105 (2): 236–243
Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, Le Marec H (1998) The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.J Clin Invest102 (7): 1377–1384
Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T (1993) Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.Proc Nail Acad Sci USA90 (1): 347–351
Han X, Kobzik L, Balligand J-L, Kelly RA, Smith TW (1996) Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca’ current in adult rabbit atrioventricular nodal cells.Circ Res78: 998–1008
Hare JM, Keaney JF Jr, Balligand JL, Loscalzo J, Smith TW, Colucci WS (1995) Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.J Clin Invest 95(1): 360–366
Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Nega-tive intropic effects of cytokines on the heart mediated by nitric oxide.Science257: 387–389
Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction.Am J Physiol265: H176–H186
Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS (1992) Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.J Clin Invest90 (2): 389–398
Oddis CV, Finkel MS (1995) Cytokine-stimulated nitric oxide production inhibits mitochondria) activity in cardiac myocytes.Biochem Biophys ResComm 213 (3): 1002–1009
Campbell DL, Stamler JS, Strauss HC (1996) Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.J Gen Physiol108 (4): 277–293
Xu L, Eu JP, Meissner G, Stamler JS (1998) Activation of the cardiac calcium release channel (Ryanodine receptor) by poly-S-nitrosylation [In Process Citation].Science279 (5348): 234–237
Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A (2002) Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.Circ Res90 (9): 959–965
Malik AB, Geha AS (1975) Role of adrenergic mechanisms in the development of cardiac hypertrophy.Proc Soc Exp Biol Med150 (3): 796–800
Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, Shannon RP, Bishop SP, Vatner SF (1997) Effects of chronic beta-adrenergic receptor stimulation in mice [In Process Citation].J MolCellCardiol29 (10): 2735–2746
Stein B, Bartel S, Kirchhefer U, Kokott S, Krause EG, Neumann J, Schmitz W, Scholz H (1996) Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. AmJ Physiol270 (6 Pt 2): H2021–2028
Communal C, Singh K, Pimentel DR, Colucci WS (1998) Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the [3-adrenergic pathway.Circulation98: 1329–1334
Calderone A, Thaik CM, Takahashi N, Chang DLF, Colucci WS (1998) Nitric oxide, atrial natriuretic peptide, and cGMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.J Clin Invest101: 812–818
Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S et al (2003) Mitochondria) biogenesis in mammals: The role of endogenous nitric oxide.Science299 (5608): 896–899
Thaik CM, Calderone A, Takahashi N, Colucci WS (1995) Interleukin-113 modulates the growth and phenotype of neonatal rat cardiac myocytes.J Clin Invest96: 1093–1099
Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P (1995) Stretch-induced programmed myocyte cell death.J Clin Invest96: 2247–2259
Mannick JB, Miao XQ, Stamler JS (1997) Nitric oxide inhibits fas-induced apoptosis.J Biol Chem272 (39): 24125–24128
Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ (1995) The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor 13.J Clin Invest95: 677–685
Ing DJ, Zang J, Dzau VJ, Webster KA, Bishopric NH (1999) Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bel-x.Circ Res84 (1): 21–33
Li HL, Suzuki J, Bayna E, Zhang FM, Dalle ME, Clark A, Engler RL, Lew WY (2002) Lipopolysaccharide induces apoptosis in adult rat ventricular myocytesviacardiac AT(1) receptors. AmJ Physiol Heart Circ Physiol283 (2): H461–H467
Arstall MA, Sawyer DB, Fukazawa R, Kelly RA (1999) Cytokine-mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation.Circ Res85 (9): 829–840
Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S et al (1997) Apoptosis in the failing human heart.N Engl J Med336 (16): 1131–1141
Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.J Biol Chem266(7):4244–4250
Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.Arch Biochem Biophys298 (2): 431–437
Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly.Am J Physiol271 (5 Pt 1): C1424–437
Xia Y, Zweier JL (1997). Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages.Proc Natl Acad Sci USA94 (13): 6954–6958
Dhalla AK, Singal PK (1994) Antioxidant changes in hypertrophied and failing guinea pig hearts. AmJ Physiol266: H1280–H1285
Hill MF, Singal PK (1997) Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction.Circulation96(7):2414–2420
Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, Colucci WS (2001) Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.Circ Res89 (4): 351–356
Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ, Husain M (2002) Cardiomyocyte over-expression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death.J Clin Invest109 (6): 735–743
Heger J, Godecke A, Flogel U, Merx MW, Molojavyi A, Kuhn-Velten WN, Schrader J (2002) Cardiac-specific over-expression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. CircRes90 (1): 93–99
Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vancon AC, Huang PL, Lee RT et al (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.Circulation104 (11): 1286–1291
Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, Matsuyama T, Penninger JM (1997) iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor1. Circulation96 (2): 585–591
Kalra DK, Zhu X, Ramchandani MK, Lawrie G, Reardon MJ, Lee-Jackson D, Winters WL, Sivasubramanian N, Mann DL, Zoghbi WA (2002) Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: A potential mechanism for depressed myocardial function in hibernating myocardium in humans.Circulation105 (13): 1537–1540
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Basel AG
About this chapter
Cite this chapter
Sam, F., Sawyer, D.B., Colucci, W.S. (2003). Myocardial nitric oxide in cardiac remodeling. In: Feuerstein, G.Z., Libby, P., Mann, D.L. (eds) Inflammation and Cardiac Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8047-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8047-3_10
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9419-7
Online ISBN: 978-3-0348-8047-3
eBook Packages: Springer Book Archive